SGMOQSANGAMO THERAPEUTICS, INCvs its industry peers
A metric-by-metric comparison of SANGAMO THERAPEUTICS, INC against Biological Products, (No Diagnostic Substances) — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SGMOQEsta | — | — | — | — | -31.6%#8 | -25.5%#8 | -306.5%#3 | — | — | — | — | — |
| MEOBF | — | — | — | — | 191.4%#3 | -16.1%#5 | — | — | — | — | — | — |
| MESO | $19.6B#2 | — | — | 1141.7x#2 | 191.4%#3 | -16.1%#5 | — | — | — | — | -4.3%#1 | — |
| MOLN | $155M#5 | — | — | — | — | — | — | — | — | — | -7.5%#3 | — |
| OKYO | $71M#6 | — | — | — | — | 72.0%#2 | — | — | — | — | -36.3%#6 | — |
| PROK | — | — | — | — | 1075.0%#1 | -12.7%#4 | -18477.8%#6 | — | — | — | -30.4%#4 | — |
| QGEN | $9.4B#3 | 22.3x#1 | 2.5x#1 | 4.5x#1 | 5.7%#7 | 408.3%#1 | 22.3%#1 | 11.2%#1 | 8.8%#1 | 7#1 | -4.7%#2 | 0.6%#1 |
| SCNI | $21.2B#1 | 381.2x#2 | 2610.9x#2 | 16137.4x#3 | 99.2%#5 | -273.2%#9 | -575.3%#4 | -102.5%#3 | -110.5%#3 | — | -90.3%#9 | — |
| SLBT | $2#7 | — | — | — | — | — | — | — | — | — | -83.1%#8 | — |
| TCRX | — | — | — | — | 266.7%#2 | -1.8%#3 | -1315.4%#5 | -188.0%#4 | -8271.2%#4 | — | -81.7%#7 | — |
| VALN | $1.1B#4 | — | — | — | — | — | — | — | — | — | -34.3%#5 | — |
| VISK | — | — | — | — | — | -538.2%#10 | -20426.9%#7 | -1.8%#2 | -1.7%#2 | — | — | — |
| ZEOX | — | — | — | — | 12.5%#6 | -17.3%#7 | -103.6%#2 | -775.4%#5 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-19.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice